Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2004-03-30 · Food and Drug Administration, HHS · Notices

Notices. Notice of meeting

367 words·~2 min read·/register/2004/03/30/04-7106

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration The Seventh Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference “Solutions to Regulatory Challenges” AGENCY: Food and Drug Administration, HHS. ACTION: Notice of meeting. The Food and Drug Administration
(FDA)is announcing its seventh annual educational conference entitled “Solutions to Regulatory Challenges” cosponsored with the Orange County Regulatory Affairs Discussion Group (OCRA). The conference is intended to provide the drug, device, and biologics industries with an opportunity to interact with FDA reviewers and compliance officers from FDA's centers and district offices, as well as other industry experts. The main focus of this interactive conference will be product approval, compliance, and risk management in the three medical product areas. Industry speakers, interactive question and answer, and workshop sessions will also be included to assure open exchange and dialogue on the relevant regulatory issues. *Date and Time* : The conference will be held on June 2 and 3, 2004, from 7:30 a.m. to 5 p.m. *Location* : The conference will be held at The Irvine Marriott, 18000 Von Karman Ave., Irvine, CA. *Contact* : Ramlah Moussa, Office of Regulatory Affairs (HFR-PA200), Food and Drug Administration, 19701 Fairchild, Irvine, CA 92612, 949-608-4408, FAX: 949-608-4456, or Orange County Regulatory Affairs Discussion Group, Attention to Detail, 5319 University Dr., suite 641, Irvine, CA 92612, 949-387-9046, FAX: 949-387-9047, Web site: *http://www.ocra-dg.org* . (FDA has verified the Web site address, but is not responsible for subsequent changes to the Web site after this document publishes in the **Federal Register** .) *Registration and Meeting Information* : See OCRA Web site at *http://www.ocra-dg.org* . Contact Attention to Detail at 949-387-9046. Before May 20, 2004, registration fees are as follows: $495.00 for members, $545.00 for nonmembers, and $325.00 for FDA/government/full-time students with proper identification. After May 20, 2004, $545.00 for members, $595.00 for nonmembers, and $325.00 for FDA/government/full-time students with proper identification. The registration fee will cover actual expenses including refreshments, lunch, materials, and speaker expenses. If you need special accommodations due to a disability, please contact Ramlah Moussa at least 10 days in advance. Dated: March 24, 2004. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 04-7106 Filed 3-29-04; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.